Enliven Therapeutics Inc’s recently made public that its CHIEF SCIENTIFIC OFFICER Lyssikatos Joseph P unloaded Company’s shares for reported $0.27 million on Jun 20 ’25. In the deal valued at $21.40 per share,12,500 shares were sold. As a result of this transaction, Lyssikatos Joseph P now holds 965,188 shares worth roughly $20.42 million.
Then, Lyssikatos Joseph P bought 12,500 shares, generating $269,625 in total proceeds.
Before that, Kintz Samuel sold 12,500 shares. Enliven Therapeutics Inc shares valued at $277,292 were divested by the PRESIDENT AND CEO at a price of $22.18 per share. As a result of the transaction, Kintz Samuel now holds 952,892 shares, worth roughly $20.16 million.
Goldman initiated its Enliven Therapeutics Inc [ELVN] rating to a Buy in a research note published on June 16, 2025; the price target was $37. A number of analysts have revised their coverage, including BTIG Research’s analysts, who began to cover the stock in mid December with a ‘”a Buy”‘ rating. H.C. Wainwright began covering ELVN with “Buy” recommendation on September 09, 2024. Robert W. Baird started covering the stock on June 11, 2024. It rated ELVN as “an Outperform”.
Price Performance Review of ELVN
On Tuesday, Enliven Therapeutics Inc [NASDAQ:ELVN] saw its stock jump 4.29% to $21.16. Over the last five days, the stock has lost -8.36%. Enliven Therapeutics Inc shares have risen nearly 0.57% since the year began. Nevertheless, the stocks have fallen -5.96% over the past one year. While a 52-week high of $30.03 was reached on 01/03/25, a 52-week low of $13.30 was recorded on 04/10/25.
Levels Of Support And Resistance For ELVN Stock
The 24-hour chart illustrates a support level at 20.54, which if violated will result in even more drops to 19.92. On the upside, there is a resistance level at 21.58. A further resistance level may holdings at 22.00.
How much short interest is there in Enliven Therapeutics Inc?
A steep rise in short interest was recorded in Enliven Therapeutics Inc stocks on 2025-05-30, dropping by -0.46 million shares to a total of 6.5 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-30 was 6.96 million shares. There was a decline of -7.05%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on April 09, 2024 when Mizuho began covering the stock and recommended ‘”a Buy”‘ rating along with a $34 price target.
